Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1999 Mar-Jun;72(2-3):81–92.

Clinical epidemiology and natural history of gastroesophageal reflux disease.

A Sonnenberg 1, H B El-Serag 1
PMCID: PMC2579001  PMID: 10780569

Abstract

In the MUSE classification of gastroesophageal reflux disease (GERD), esophagitis is assessed by the presence of metaplasia, ulcer, stricture, or erosion, each being graded as absent, mild or severe. Daily reflux symptoms affect about 4 to 7 percent of the population; erosive esophagitis occurs in about 2 percent; the prevalence rate of Barrett's metaplasia is 0.4 percent; and esophageal adenocarcinoma leads to two deaths per million living population. In persons with GERD symptoms, about 20 percent are found to have erosive esophagitis, while ulcers or strictures are found in less than 5 percent of all patients with erosive esophagitis. No clear-cut temporal progression exists between successive grades of disease severity, as the most severe grade of GERD is reached at the onset of the disease. Mild forms of GERD tend to be more common in women than men, while severe GERD characterized by erosive esophagitis, esophageal ulcer, stricture or Barrett's metaplasia are far more common in men than women. All forms of GERD affect Caucasians more often than African Americans or Native Americans. The prevalence of GERD is high among developed countries in North America and Europe and relatively low in developing countries in Africa and Asia. During the past three decades, hospital discharges and mortality rates of gastric cancer, gastric ulcer and duodenal ulcer have declined, while those of esophageal adenocarcinoma and GERD have markedly risen. These opposing time trends suggest that corpus gastritis secondary to Helicobacter pylori infection protects against GERD. This hypothesis is consistent with the geographic and ethnic distributions of GERD. Case-control studies also indicate that cases with erosive esophagitis are less likely to harbor active or chronic corpus gastritis than controls without esophagitis.

Full text

PDF
81

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyd E. J. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol. 1996 Aug;91(8):1539–1543. [PubMed] [Google Scholar]
  2. Cameron A. J., Zinsmeister A. R., Ballard D. J., Carney J. A. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990 Oct;99(4):918–922. doi: 10.1016/0016-5085(90)90607-3. [DOI] [PubMed] [Google Scholar]
  3. Champion G., Richter J. E., Vaezi M. F., Singh S., Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology. 1994 Sep;107(3):747–754. doi: 10.1016/0016-5085(94)90123-6. [DOI] [PubMed] [Google Scholar]
  4. Chang C. S., Poon S. K., Lien H. C., Chen G. H. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol. 1997 Apr;92(4):668–671. [PubMed] [Google Scholar]
  5. El-Omar E. M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., Williams C., Ardill J. E., McColl K. E. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997 Jul;113(1):15–24. doi: 10.1016/s0016-5085(97)70075-1. [DOI] [PubMed] [Google Scholar]
  6. Goff J. S., Barnett J. L., Pelke T., Appelman H. D. Collagenous colitis: histopathology and clinical course. Am J Gastroenterol. 1997 Jan;92(1):57–60. [PubMed] [Google Scholar]
  7. Goldman J., Bennett J. R. Gastro-oesophageal reflux and respiratory disorders in adults. Lancet. 1988 Aug 27;2(8609):493–495. doi: 10.1016/s0140-6736(88)90132-8. [DOI] [PubMed] [Google Scholar]
  8. Gutierrez O., Melo M., Segura A. M., Angel A., Genta R. M., Graham D. Y. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol. 1997 Jul;32(7):664–668. doi: 10.3109/00365529708996515. [DOI] [PubMed] [Google Scholar]
  9. Hirschowitz B. I. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology. 1991 Nov;101(5):1149–1158. doi: 10.1016/0016-5085(91)90062-p. [DOI] [PubMed] [Google Scholar]
  10. Hirschowitz B. I. Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls. Dig Dis Sci. 1996 Nov;41(11):2115–2122. doi: 10.1007/BF02071389. [DOI] [PubMed] [Google Scholar]
  11. Klauser A. G., Schindlbeck N. E., Müller-Lissner S. A. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990 Jan 27;335(8683):205–208. doi: 10.1016/0140-6736(90)90287-f. [DOI] [PubMed] [Google Scholar]
  12. Labenz J., Blum A. L., Bayerdörffer E., Meining A., Stolte M., Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997 May;112(5):1442–1447. doi: 10.1016/s0016-5085(97)70024-6. [DOI] [PubMed] [Google Scholar]
  13. Lanas A., Hirschowitz B. I. Significant role of aspirin use in patients with esophagitis. J Clin Gastroenterol. 1991 Dec;13(6):622–627. doi: 10.1097/00004836-199112000-00005. [DOI] [PubMed] [Google Scholar]
  14. Löf L., Götell P., Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol. 1993 Feb;28(2):113–118. doi: 10.3109/00365529309096056. [DOI] [PubMed] [Google Scholar]
  15. Malaty H. M., Evans D. G., Evans D. J., Jr, Graham D. Y. Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology. 1992 Sep;103(3):813–816. doi: 10.1016/0016-5085(92)90011-m. [DOI] [PubMed] [Google Scholar]
  16. Miller L. S., Vinayek R., Frucht H., Gardner J. D., Jensen R. T., Maton P. N. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology. 1990 Feb;98(2):341–346. doi: 10.1016/0016-5085(90)90823-j. [DOI] [PubMed] [Google Scholar]
  17. Molloy R. M., Sonnenberg A. Relation between gastric cancer and previous peptic ulcer disease. Gut. 1997 Feb;40(2):247–252. doi: 10.1136/gut.40.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nandurkar S., Talley N. J., Martin C. J., Ng T. H., Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut. 1997 Jun;40(6):710–715. doi: 10.1136/gut.40.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nomura A., Stemmermann G. N., Chyou P. H., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med. 1994 Jun 15;120(12):977–981. doi: 10.7326/0003-4819-120-12-199406150-00001. [DOI] [PubMed] [Google Scholar]
  20. Ohara S., Sekine H., Iijima K., Moriyama S., Nakayama Y., Kinpara T., Kato K., Asaki S., Katakura T., Ikeda T. [Gastric mucosal atrophy and prevalence of Helicobacter pylori in reflux esophagitis of the elderly]. Nihon Shokakibyo Gakkai Zasshi. 1996 Apr;93(4):235–239. [PubMed] [Google Scholar]
  21. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  22. Recht M. P., Levine M. S., Katzka D. A., Reynolds J. C., Saul S. H. Barrett's esophagus in scleroderma: increased prevalence and radiographic findings. Gastrointest Radiol. 1988;13(1):1–5. doi: 10.1007/BF01889012. [DOI] [PubMed] [Google Scholar]
  23. Saladin T. A., French A. B., Zarafonetis C. J., Pollard H. M. Esophageal motor abnormalities in scleroderma and related diseases. Am J Dig Dis. 1966 Jul;11(7):522–535. doi: 10.1007/BF02233564. [DOI] [PubMed] [Google Scholar]
  24. Sonnenberg A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther. 1995;9 (Suppl 2):3–12. [PubMed] [Google Scholar]
  25. Sontag S. J., Schnell T. G., Miller T. Q., Khandelwal S., O'Connell S., Chejfec G., Greenlee H., Seidel U. J., Brand L. Prevalence of oesophagitis in asthmatics. Gut. 1992 Jul;33(7):872–876. doi: 10.1136/gut.33.7.872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Spechler S. J., Zeroogian J. M., Antonioli D. A., Wang H. H., Goyal R. K. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994 Dec 3;344(8936):1533–1536. doi: 10.1016/s0140-6736(94)90349-2. [DOI] [PubMed] [Google Scholar]
  27. TREACY W. L., BAGGENSTOSS A. H., SLOCUMB C. H., CODE C. F. SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS. Ann Intern Med. 1963 Sep;59:351–356. doi: 10.7326/0003-4819-59-3-351. [DOI] [PubMed] [Google Scholar]
  28. Vaezi M. F., Richter J. E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996 Nov;111(5):1192–1199. doi: 10.1053/gast.1996.v111.pm8898632. [DOI] [PubMed] [Google Scholar]
  29. Vicari J. J., Peek R. M., Falk G. W., Goldblum J. R., Easley K. A., Schnell J., Perez-Perez G. I., Halter S. A., Rice T. W., Blaser M. J. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998 Jul;115(1):50–57. doi: 10.1016/s0016-5085(98)70364-6. [DOI] [PubMed] [Google Scholar]
  30. Weston S., Thumshirn M., Wiste J., Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol. 1998 Jul;93(7):1085–1089. doi: 10.1111/j.1572-0241.1998.00334.x. [DOI] [PubMed] [Google Scholar]
  31. Wilkins W. E., Ridley M. G., Pozniak A. L. Benign stricture of the oesophagus: role of non-steroidal anti-inflammatory drugs. Gut. 1984 May;25(5):478–480. doi: 10.1136/gut.25.5.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Williamson W. A., Ellis F. H., Jr, Gibb S. P., Shahian D. M., Aretz H. T., Heatley G. J., Watkins E., Jr Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med. 1991 Nov;151(11):2212–2216. doi: 10.1001/archinte.151.11.2212. [DOI] [PubMed] [Google Scholar]
  33. Xia H. H., Talley N. J. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol. 1998 Mar;93(3):394–400. doi: 10.1111/j.1572-0241.1998.00394.x. [DOI] [PubMed] [Google Scholar]
  34. el-Serag H. B., Sonnenberg A. Associations between different forms of gastro-oesophageal reflux disease. Gut. 1997 Nov;41(5):594–599. doi: 10.1136/gut.41.5.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. el-Serag H. B., Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997 Sep;113(3):755–760. doi: 10.1016/s0016-5085(97)70168-9. [DOI] [PubMed] [Google Scholar]
  36. el-Serag H. B., Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998 Sep;43(3):327–333. doi: 10.1136/gut.43.3.327. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES